AI Insight
A study published in Frontiers in Pediatrics found that children diagnosed with chest tightness variant asthma (CTVA) exhibit significantly elevated levels of fractional exhaled nitric oxide (FeNO) compared to healthy controls. Additionally, these patients showed reduced small airway function measurements, suggesting that FeNO testing and small airway assessment may serve as useful diagnostic markers for this asthma subtype.
Why it matters
This research could improve the diagnosis and monitoring of CTVA in children, a condition that may be overlooked when typical wheezing symptoms are absent. The identification of elevated FeNO as a biomarker may enable earlier intervention and more targeted treatment strategies for pediatric patients presenting primarily with chest tightness rather than classic asthma symptoms.
Understand the Science
Children with chest tightness variant asthma (CTVA) have higher fractional exhaled nitric oxide (FeNO) levels and lower measures of small airway function, according to a study published online Aug. 10 in Frontiers in Pediatrics.
Source: Fractional exhaled nitric oxide elevated in pediatric chest tightness-variant asthma